YB18
YB18 is an antimicrobial peptide targeting Gram-negative bacteria. YB18 exhibits low hemolytic activity, acceptable cytocompatibility at antibacterial-related concentrations, and membrane-associated bactericidal behavior. YB18 disrupts bacterial membrane permeability and membrane potential. In an in vivo wound model infected with Escherichia coli, topical administration of YB18 reduces bacterial load. YB18 can be used for research on Gram-negative bacterial infections.
For research use only. We do not sell to patients.
- Formula: C51H92N18O8
- Molecular Weight:1085.39
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
YB18 inhibits the growth of P. aeruginosa ATCC 27853, E. coli MG1655, K. pneumoniae ATCC 700603, and A. baumannii ATCC 19606, with MIC values of 16, 8, 8, and 16 μM, and MBC values of 16, 32, 128, and 64 μM, respectively[1].
YB18 (8-64 μM; 18 h) inhibits the growth of clinically isolated Gram-negative strains, with MIC values ranging from 8 to 64 μM against *E. coli*, *K. pneumoniae*, *P. aeruginosa* and *A. baumannii* strains[1].
YB18 (2-256 μM; 1 h) exhibits low hemolytic activity against rat red blood cells, with a hemolysis rate of less than 1% even at a concentration as high as 256 μM[1].
YB18 (2-64 μM; 24 h) exhibits favorable cytocompatibility with RAW 264.7, L929, and NIH 3T3 cells at antibacterial relevant concentrations of 8-16 μM, whereas reduced cell viability is observed at higher concentrations[1].
YB18 (0-120 min) shows limited stability in 25% rat serum, retaining only 5% of its initial concentration after 120 min of incubation[1].
YB18 (6-15 mM) forms a viscoelastic hydrogel at a concentration of 12 mM in 0.8× PBS, which exhibits stable gel-like mechanical properties, partial self-recovery behavior, and a dense fibrous self-assembled microstructure[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:RAW 264.7, L929, and NIH 3T3 cell lines
-
Concentration:2-64 μM
-
Incubation Time:24 h
-
Result:Maintained acceptable cell viability at antibacterial-relevant concentrations (8-16 μM) across all three cell lines, with viability decreasing in a concentration-dependent manner at higher concentrations (32-64 μM).
In Vivo
YB18 (12 mM hydrogel in 0.8× PBS; topical; once daily for 11 consecutive days) reduces E. coli load in wounds of infected mice, accelerates wound healing and improves tissue repair, with antibacterial efficacy comparable to that of Polymyxin B (HY-149179)[1].
YB18 (12 mM hydrogel in 0.8× PBS; topical administration; once daily for 5 consecutive days) shows preliminary local tolerability in male and female BALB/c mice, with no skin abnormalities or histological injuries observed[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c (male)[1]
-
Dosage:10 mg/kg; 20 mg/kg
-
Administration:topical; every 24 h; 2 doses total
-
Result:Achieved an approximately 2-3 log10 CFU/g reduction in wound bacterial burden relative to the saline control.
Showed antibacterial efficacy comparable to that of polymyxin B under the tested conditions.
-
Animal Model:BALB/c[1]
-
Dosage:12 mM YB18 hydrogel in 0.8× PBS
-
Administration:topical; once daily; 11 days total
-
Result:Reduced viable bacterial counts in wound tissues to levels comparable to polymyxin B and significantly lower than the PBS control on day 3.
Showed faster wound area reduction than the infected PBS group from day 0 to day 11, with more rapid wound contraction and closure observed via photographic and image analysis.
Revealed improved tissue repair relative to the infected PBS group via endpoint H&E staining.
-
Animal Model:BALB/c (male, female)[1]
-
Dosage:12 mM YB18 hydrogel in 0.8× PBS
-
Administration:topical; once daily; 5 days total
-
Result:Showed no obvious macroscopic skin abnormalities in male or female mice during the 5-day treatment period.
Did not reveal overt treatment-related epidermal or dermal damage in either sex relative to PBS-treated controls via endpoint H&E staining.
Chemical Information
-
Molecular Weight 1085.39
-
Formula C51H92N18O8
-
SMILES
O=C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(C)C)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(C)C)C(N)=O)=O)=O)=O)=O)=O)=O)[C@H](CCCNC(N)=N)N
-
Sequence
Arg-Phe-Arg-Leu-Ile-Leu-Arg-Leu-NH2
-
Sequence Shortening
RFRLILRL-NH2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Fluorescent plasma-membrane potential dye assay
Fluorescent plasma-membrane potential dye assays measure changes in cell membrane potential using voltage-sensitive dyes whose fluorescence changes when cells depolarize or hyperpolarize. Anionic bis-oxonol dyes such as DiBAC4(3) enter depolarized cells more readily and show increased fluorescence after intracellular binding, while hyperpolarization reduces dye accumulation and fluorescence. FMP/FLIPR membrane-potential dyes are used for faster, homogeneous microplate assays of ion-channel or receptor-mediated membrane-potential changes.
-
Transepithelial/transendothelial electrical resistance assay
TEER measures electrical resistance across epithelial or endothelial monolayers cultured on permeable supports, and the readout reflects ionic conductance through the cell barrier, especially the paracellular pathway regulated by junctional integrity. TEER can be measured without destroying the monolayer and is commonly used before or during transport, permeability, barrier-disruption, and barrier-maturation experiments. TEER values are influenced by biological maturation and technical conditions; reported factors include temperature, medium formulation, passage number, electrode geometry, membrane properties, and junctional length during early monolayer maturation. Therefore, TEER should be interpreted with blank-insert subtraction, area normalization, repeated readings, and, when possible, orthogonal barrier readouts such as FITC-dextran flux or tight-junction staining.
-
Gram Staining of Tissue Sections
Gram staining of tissue sections is a histochemical technique used to differentiate Gram-positive and Gram-negative bacteria within histological specimens based on differences in bacterial cell wall structure and dye retention, adapted from classical bacteriological Gram staining into tissue-compatible “histological Gram stain” variants. In tissue applications, modifications of the Brown-Hopps and Brown-Brenn methods are commonly used to improve differentiation of microorganisms embedded within host connective tissue and to reduce overstaining or loss of Gram-negative signal, which are known limitations of earlier approaches. The principle relies on crystal violet-iodine complex retention in Gram-positive organisms and subsequent decolorization and counterstaining steps that allow contrast visualization of Gram-negative organisms against tissue background.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)